What is it about?
When cells can no longer function properly, they eventually die. Abnormailities in these normal cell-death processes can contribute to diseases such as cancer. However, these same cell-death processes can also be used to fight cancer. Immunogenic Cell Death (ICD), can make cancer cells more visible to the immune system, encouraging it to specifically recognize and attack cancer cells. Understanding how ICD works could help researchers develop new effective cancer treatments.
Featured Image
Photo by National Institute of Allergy and Infectious Diseases on Unsplash
Why is it important?
we provide a clear and up-to-date overview of how the death of cancer cells can activate the body’s immune system to recognize and fight cancer, showing the potential role of ICD in cancer treatment, and the challenges that researchers still face. The review is particularly useful for students, researchers, and healthcare professionals who want to understand how ICD may contribute to the development of new and effective cancer immunotherapies.
Perspectives
This publication is particularly valuable because it presents cancer treatment from an interesting angle: the way cancer cells die may be just as important as the fact that they die. I find this concept especially important because it connects our understanding of cell biology with the development of cancer immunotherapy
Katherine Yaacoub
Notre Dame University Lebanon
Read the Original
This page is a summary of: Immunogenic Cell Death: Unlocking New Frontiers in Cancer Immunotherapy, Cancer Innovation, June 2026, Tsinghua University Press,
DOI: 10.1002/cai2.70069.
You can read the full text:
Contributors
The following have contributed to this page
